+20.6%
ICE vs MRNA
+945.0%
-924.4%
-29.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.3% | +13.1% | -10.8% | +2.3% |
| 7D | +12.2% | +20.6% | -8.5% | +12.0% |
| 30D | +15.0% | +27.1% | -12.2% | +14.7% |
| 3M | +17.6% | +353.4% | -335.7% | +14.7% |
| 6M | +12.6% | +446.3% | -433.7% | +7.8% |
| YTD | +9.1% | +776.2% | -767.0% | +0.4% |
| 1Y | +20.6% | +987.9% | -967.3% | +6.7% |
| All | +20.6% | +945.0% | -924.4% | +6.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling